/study / lectures / Surgical Special

Brain-Death Donor Management — Hormonal Resuscitation + Organ Protection

TEXT

Surgical Special · 7 min read

Once brain death is declared, the goal flips from saving the patient to saving the organs. The physiology is hostile: catecholamine storm gives way to vasoplegia, DI, and hypothermia. Hormonal resuscitation rescues organs that would otherwise be lost.

After this lesson you can

3 min read6 sections

Pathophysiology after declaration

KeyBrain death triggers a stereotyped cascade.

PHASE 1catecholamine storm: massive sympathetic surge as brainstem dies, causing severe hypertension, tachycardia, and intense vasoconstriction.

This phase can damage the heart (neurogenic myocardial injury, takotsubo-like pattern) and lungs (neurogenic pulmonary edema).

PHASE 2sympathetic collapse: complete loss of central sympathetic outflow profound vasoplegia, bradycardia, spinal shock.

PHASE 3endocrine failure: anterior + posterior pituitary fail central diabetes insipidus (DI), adrenal insufficiency, low T3/T4, hyperglycemia from insulin resistance.

PHASE 4poikilothermia: loss of hypothalamic thermoregulation drift toward room temp.

Pheochromocytoma intraoperative crisis: severe HTN, tachycardia, arrhythmias on tumor manipulation; manage with phentolamine, nitroprusside, nicardipine, magnesium for arrhythmias; avoid sympathomimetics. After tumor resection prepare for hypotension - volume and pressors.

Hormonal resuscitation protocol

Standard package (UNOS / OPTN consensus): T3 4 mcg IV bolus then 3 mcg/hr infusion (or T4 20 mcg bolus + 10 mcg/hr if T3 unavailable) — improves cardiac function + reduces inotrope requirement

methylprednisolone 15 mg/kg IV bolus (or hydrocortisone 100 mg IV q6) — anti-inflammatory + adrenal replacement

vasopressin 1-2 U IV bolus then 0.5-2.4 U/hr infusion — restores SVR + treats DI simultaneously

insulin gtt to target glucose 120-180 mg/dL

This combination ('UNOS hormone package') has been shown to increase organs-transplanted-per-donor by 22-25% (Rosendale et al., Transplantation 2003).

Diabetes insipidus + fluid balance

KeyDI from posterior pituitary failure causes massive dilute urine output (often >300-500 mL/hr, urine osmolality <200, urine specific gravity <1.005, rising serum Na).

Hypernatremia (>155) damages the liver allograft — must correct before recovery.

Treatment: desmopressin (DDAVP) 1-4 mcg IV titrated to UO <300 mL/hr; alternative is vasopressin infusion (already on board for vasoplegia).

Replace urine losses with hypotonic fluid (D5W or 0.45% NS) to correct hypernatremia gradually (drop Na no faster than 0.5 mEq/L/hr to avoid cerebral edema in the brain that's no longer at risk, but rapid swings can still affect organ water balance).

Target serum Na <155 (ideally 135-145) by procurement time.

Hemodynamic + organ-specific targets

Standard targets

MAP 60-70 mmHg (some centers aim 65-80 for renal perfusion)
CVP 6-10 (low-normal — avoid volume overload, which hurts lung donor)
urine output 1-3 mL/kg/hr
hemoglobin >7-9 g/dL
temperature 36-37°C with active warming
lactate trending down

LUNG donor: lung-protective ventilation (TV 6-8 mL/kg IBW, PEEP 8-10, target PaO2 ~100 mmHg, not higher — hyperoxia worsens ischemia-reperfusion in the recipient), conservative fluids, recruitment maneuvers, bronchoscopy + suctioning.

HEART donor

minimize inotropes (excess catecholamines damage myocytes — wean as hormonal package allows)
ECG + echo + sometimes cath
troponin trending

LIVER + KIDNEYavoid hypotension, ensure perfusion, normal glucose, normal Na.

Necrotizing enterocolitis (NEC) in preterm neonates: high-risk anesthesia with sepsis, hemodynamic instability and DIC; aggressive resuscitation, lung-protective ventilation, and broad-spectrum antibiotics required.

OR + procurement coordination

KeyMulti-organ recovery is a coordinated dance — multiple surgical teams (heart, lung, liver, kidney, pancreas, small bowel) each with their own preferences and timelines.

The anesthetist's job is to deliver an organ-perfused patient and to facilitate the procurement sequence.

No anesthesia is given for analgesic purposes (brain death = no perception), BUT neuromuscular blockade IS needed (spinal cord reflexes are preserved → movement during incision).

Maintain ventilation, fluids, pressors, and hormonal package up to aortic cross-clamp.

After cross-clamp and flush, the donor is removed from ventilator/support.

Documentation

declaration time
hemodynamics throughout
exact dose + time of all hormones + fluids
cross-clamp time

Legal + ethical requirement: brain-death declaration must be by physician(s) independent of the transplant team.

Conservative fluid management in ARDS targeting near-neutral/negative balance reduces ventilator days; avoid unnecessary boluses, use diuretics if needed, monitor with daily weights, I/O, hemodynamics.

Donation after circulatory death (DCD)

KeyDistinct from brain-death (DBD) pathway.

DCD donors do not meet brain-death criteria; life-sustaining therapy is withdrawn (typically extubation in OR or ICU after family decision), circulation ceases, the patient is declared dead by circulatory criteria, and after a mandatory wait (typically 2-5 min asystole — 'no-touch period' to ensure auto-resuscitation will not occur), procurement begins.

Anesthesia role: comfort measures during withdrawal (opioids + benzodiazepines as needed for distress — clearly separated from the procurement process, NOT to hasten death), monitoring, declaration documentation.

Warm ischemia time (from withdrawal to cold perfusion) directly affects organ viability — only kidneys + (selected centers) liver + lung are commonly recovered from DCD.

Heart DCD with normothermic regional perfusion or ex-vivo perfusion is emerging.

End of lecture

You just covered ~3 minutes of Surgical Special. Reinforce with a few questions while it's fresh.

Practice questions →Back to lectures